ACLS exhibits strong financial health per the Piotroski F-Score of 7/9, indicating robust operational efficiency and stability, though the absence of an Altman Z-Score raises caution regarding default risk. The stock trades at a premium to its Graham Number ($53.67) and intrinsic value ($26.60), suggesting valuation is driven by growth expectations rather than conservative fundamentals. Despite a recent earnings decline (YoY EPS -28.3%), the company has consistently beaten estimates over the past four quarters with an average surprise of 37.69%, signaling strong earnings quality. However, negative revenue and earnings growth, combined with bearish insider activity, introduce near-term caution. The 1-year return of +43% reflects strong momentum, but recent 6-month and 1-month declines suggest profit-taking or sector rotation.